EAHP Statement 5: Patient Safety and Quality Assurance

Showing results 21 - 30 of 100

Sorted by most recent

TitleAuthorDate

Prevalence of compliance with PIMDINAC criteria among elderly people living with HIV and in non-infected outpatients with other chronic diseases

Maria Dolores Cantudo-Cuenca, Antonio Gutiérrez-Pizarraya, Patricia García-Lloret, Estefanía Gabella-Bazarot, Ramón Morillo-Verdugo

30 December 2022

Factors influencing the acceptability of different devices for subcutaneous drug delivery: a cross-sectional observational study from the patient’s point of view

Lisa Pivato, Daniele Mengato, Federica Torni, Claudia Battistutta, Francesca Temporin, Francesca Venturini

21 February 2023

Retrospective review of medication-related incidents at a major teaching hospital and the potential mitigation of these incidents with electronic prescribing and medicines administration

Millie Cattell, Kira Hyde, Brian Bell, Thomas Dawson, Tim Hills, Barbara Iyen, Adam Khimji, Anthony Avery

3 March 2023

Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Zealand

Rebecca Larcombe, Kingsley Coulthard, Vaughn Eaton, Andrew Tai, Stephanie Reuter, Michael Ward

20 December 2022

Patient safety culture and medication safety in European intensive care units: a focus group study

Raisa Laaksonen, Andrea Rahel Burch, Jana Lass, Suzanne McCarthy, Moninne Howlett, Virginia Silvari

29 May 2024

Lu-Dotatate administration using an infusion pump or a peristaltic pump: comparison of two methods

Charlotte Donzé, Léa Rubira, Lore Santoro, Malissone Viarasakd, Pierre Olivier Kotzki, Emmanuel Deshayes, Cyril Fersing

13 September 2022

Standardisation of intravenous infusion therapy for paediatrics: big challenges for the little patients

Irene Taladriz-Sender, Silvia Manrique-Rodríguez, Cecilia M Fernández-Llamazares, Ana Herranz-Alonso, María Sanjurjo-Sáez

19 December 2022

Using Healthcare Failure Mode and Effect Analysis in prospective medication safety risk management in secondary care inpatient wards

Päivi Marjatta Sova, Anna-Riia Holmström, Marja Airaksinen, Sami Sneck

5 October 2022

Impact of implementing the aseptic compounding management system, Medcura, on internal error rates within an oncology pharmacy aseptic unit: a mixed methods evaluation

Emily Smith, Andy Fox, Graeme Willmers, Deborah Wright, Beth Stuart

14 October 2022

Adverse drug effect in the context of drug shortage: the CIRUPT prospective study from the French pharmacovigilance network

Delphine Bourneau-Martin, Aurelie Grandvuillemin, Marina Babin, Charlotte Mullet, Hillary Said, Morgane Cellier, Helene Geniaux, Sophie Gautier, Mathilde Beurrier, Gwenaelle Veyrac, Laurence Lagarce, Marie-Laure Laroche, Marie Briet

15 April 2024

Prev 1 234 5 6 7 8 9 10 Next